Researchers Identify Novel Link Between Bone Marrow Fat and Accelerated Bone Loss in Obesity

Researchers discover that bone marrow fat in obesity triggers PD-L1 signaling, causing immune suppression and accelerated bone loss. New targets for treatment.

By: AXL Media

Published: Apr 25, 2026, 4:15 AM EDT

Source: Information for this report was sourced from Sichuan University and Bone Research (Nature).

The Metabolic Shift in Skeletal Integrity

For decades, the prevailing medical consensus suggested that higher body weight provided a protective effect on skeletal health through increased mechanical loading. However, a groundbreaking study led by Dr. Clifford J. Rosen and Dr. Sergey Ryzhov at the MaineHealth Institute for Research has dismantled this notion. Published on March 20, 2026, the research demonstrates that obesity fundamentally reshapes the bone marrow environment, turning it from a supportive structure into a site of active bone degradation. By utilizing diet-induced obese mouse models, the team discovered that the rapid expansion of bone marrow adipose tissue (BMAT) acts as a primary catalyst for systemic skeletal weakening, rather than a passive byproduct of weight gain.

PD-L1 Signaling and Immune Suppression

The investigative team identified a specific molecular mechanism where bone marrow fat alters the profile of adipocytes, increasing the production of MCP-1 signaling molecules. This process recruits myeloid immune cells and induces them to express PD-L1, a protein typically associated with suppressing immune responses in cancer. These PD-L1-expressing cells were found to inhibit T-cell activity within the bone marrow, creating a localized immunosuppressive microenvironment. This shift not only weakens the body’s internal defense mechanisms but also provides a "molecular green light" for cellular processes that are traditionally kept in check by a balanced immune system.

A New Driver for Osteoclastogenesis

Perhaps the most significant finding of the study is the direct link between immune checkpoint pathways and bone remodeling. The researchers observed that PD-L1-expressing myeloid cells interact directly with PD-1 receptors on osteoclast precursors. This interaction promotes their differentiation into mature osteoclasts—the cells responsible for breaking down bone tissue. By blocking this PD-1/PD-L1 pathway during the early stages of cell formation, the researchers were able to significantly reduce the rate of bone resorption. This reveals that the same pathways used by tumors to evade the immune system are being repurposed by bone marrow fat to accelerate bone loss.